This is a great development, probably the best development this year.
Imagine if Cynata stem cells are able to remove the need for immunosuppressants after kidney transplant!
Also another one where the trial is funded and managed by a university and all Cynata has to do is provide the cells.
Hopefully it starts in early 2023 rather than mid or late. But at least getting those 10 patients should be pretty fast once it starts.
- Forums
- ASX - By Stock
- Ann: New Kidney Transplantation Clinical Trial for Cynata & LUMC
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.5¢

This is a great development, probably the best development this...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 16.0¢ | $29.18K | 176.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 66467 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 66467 | 0.160 |
4 | 181490 | 0.155 |
5 | 318045 | 0.150 |
4 | 81775 | 0.145 |
4 | 307863 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 65000 | 1 |
0.185 | 35419 | 2 |
0.190 | 114978 | 3 |
0.195 | 5764 | 1 |
0.200 | 55400 | 2 |
Last trade - 15.59pm 25/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online